Skip directly to site content
Are You Still There?
Due to inactivity, you will be signed out in two minutes unless you click 'Continue'.

Are you still there?

Due to inactivity, you will be signed out in two minutes unless
you click 'Continue'.

Panel: 
AR Bank #

Biosample Accession #:

   


Panel:    |  Imipenem/relebactam (IMR)  |  Fluoroquinolones+ aminoglycosides Pseudomonas aeruginosa verification (PFA) (Custom)


MIC (μg/ml) Results and Interpretation
Drug MIC (μg/ml) INT
SDD (Susceptible Dose Dependent)
S – I –R Interpretation (INT) derived from CLSI 2024 M100 S34
Device manufacturers and users of FDA cleared devices shall consult the FDA’s Antibacterial Susceptibility Test Interpretive Criteria       website for breakpoints recognized or recommended by FDA, and for information regarding FDA exceptions or additions to the applicable, recognized consensus standard.
Molecular Mechanisms of Resistance
CategoryGene
No data available
 
Disclaimer:
Propagation
MEDIUM
Medium: Label

GROWTH CONDITIONS
Temperature: Label°C
Atmosphere: Label

PROPAGATION PROCEDURE
Label
Storage Temperature & Biosafety
STORAGE TEMPERATURE: °C

BIOSAFETY LEVEL:


Disclaimer:
Isolate History
Date Action Performed
06/14/23Drug was removed: 'Gentamicin'
02/13/23MLST was updated: from '---' to '1042(Pasteur)'
12/07/22MIC was updated with a new value for Cefepime/zidebactam: from '---' to '4'
12/07/22Drug was added: Cefepime/zidebactam
Top of Page
TOP